Bone Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Cancer, including details on symptoms, types, treatment.

Volume 7 (2010), Issue 10 (October)

1. Outcome after microsurgery in 14 patients with spinal cavernomas and review of the literature.
   J Neurosurg Spine, 13(4): 524-34. [Abstract] [Full-text]
2. Total en bloc spondylectomy for lung cancer metastasis to the spine.
   J Neurosurg Spine, 13(4): 414-7. [Abstract] [Full-text]
3. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
   J Biol Chem, 285(41): 31427-34. [Abstract] [Full-text]
4. RT-PCR for the detection of translocations in bone and soft tissue tumours in formalin-fixed paraffin-embedded tissues.
   Methods Mol Biol, 688: 257-68. [Abstract] [Full-text]
5. RT-PCR for the detection of translocations in bone and soft tissue tumours in formalin-fixed paraffin-embedded tissues.
   Methods Mol Biol, 688: 257-68. [Abstract] [Full-text]
6. Big toe metastases as first clinical sign of occult bronchogenic carcinoma.
   J Coll Physicians Surg Pak, 20(10): 699-700. [Abstract] [Full-text]
7. Pontine haemorrhage due to chondrosarcoma of the skull base.
   J Coll Physicians Surg Pak, 20(10): 692-4. [Abstract] [Full-text]
8. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
   Cancer Chemother Pharmacol, 66(6): 1059-63. [Abstract] [Full-text]
9. Modifying the Burow's triangles of traditional transposition flaps for the repair of adjacent nasal defects.
   J Am Acad Dermatol, 63(5): 836-41. [Abstract] [Full-text]
10. Modifying the Burow's triangles of traditional transposition flaps for the repair of adjacent nasal defects.
    J Am Acad Dermatol, 63(5): 836-41. [Abstract] [Full-text]
11. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Cancer Chemother Pharmacol, 66(6): 1059-63. [Abstract] [Full-text]
12. Antitumor activity of polyuridylic acid in human soft tissue and bone sarcomas.
    J Surg Res, 164(1): e107-14. [Abstract] [Full-text]
13. Antitumor activity of polyuridylic acid in human soft tissue and bone sarcomas.
    J Surg Res, 164(1): e107-14. [Abstract] [Full-text]
14. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
    Radiology, 257(2): 523-31. [Abstract] [Full-text]
15. Trilobed flap reconstruction for distal nasal skin defects.
    Dermatol Surg, 36(11): 1726-35. [Abstract] [Full-text]
16. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Oncogene, 29(42): 5687-99. [Abstract] [Full-text]
17. Trilobed flap reconstruction for distal nasal skin defects.
    Dermatol Surg, 36(11): 1726-35. [Abstract] [Full-text]
18. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
    Ophthalmology, 117(11): 2222-8. [Abstract] [Full-text]
19. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(4): 998-1004. [Abstract] [Full-text]
20. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Int J Radiat Oncol Biol Phys, 78(4): 992-7. [Abstract] [Full-text]
21. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
    Ophthalmology, 117(11): 2222-8. [Abstract] [Full-text]
22. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(4): 998-1004. [Abstract] [Full-text]
23. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Int J Radiat Oncol Biol Phys, 78(4): 992-7. [Abstract] [Full-text]
24. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Int J Radiat Oncol Biol Phys, 78(4): 998-1004. [Abstract] [Full-text]
25. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Int J Radiat Oncol Biol Phys, 78(4): 992-7. [Abstract] [Full-text]
26. Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases.
    Am J Surg Pathol, 34(11): 1647-55. [Abstract] [Full-text]
27. PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review.
    Am J Surg Pathol, 34(11): 1622-9. [Abstract] [Full-text]
28. Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases.
    Am J Surg Pathol, 34(11): 1647-55. [Abstract] [Full-text]
29. PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review.
    Am J Surg Pathol, 34(11): 1622-9. [Abstract] [Full-text]
30. Reduced methotrexate clearance and renal impairment in a boy with osteosarcoma and earlier undetected autosomal dominant polycystic kidney disease (ADPKD).
    J Pediatr Hematol Oncol, 32(8): e314-6. [Abstract] [Full-text]
31. Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience.
    Jpn J Clin Oncol, 40(11): 1092-8. [Abstract] [Full-text]
32. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
    Jpn J Clin Oncol, 40(11): 1060-7. [Abstract] [Full-text]
33. Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.
    Pediatr Blood Cancer, 55(6): 1224-6. [Abstract] [Full-text]
34. Anaplastic ependymoma with sclerotic bone metastases.
    Pediatr Blood Cancer, 55(6): 1204-6. [Abstract] [Full-text]
35. Reduced methotrexate clearance and renal impairment in a boy with osteosarcoma and earlier undetected autosomal dominant polycystic kidney disease (ADPKD).
    J Pediatr Hematol Oncol, 32(8): e314-6. [Abstract] [Full-text]
36. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
    Pediatr Blood Cancer, 55(6): 1096-102. [Abstract] [Full-text]
37. Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience.
    Jpn J Clin Oncol, 40(11): 1092-8. [Abstract] [Full-text]
38. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
    Jpn J Clin Oncol, 40(11): 1060-7. [Abstract] [Full-text]
39. Heavy ion radiotherapy during pregnancy.
    Fertil Steril, 94(6): 2329.e5-7. [Abstract] [Full-text]
40. Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.
    Pediatr Blood Cancer, 55(6): 1224-6. [Abstract] [Full-text]
41. Anaplastic ependymoma with sclerotic bone metastases.
    Pediatr Blood Cancer, 55(6): 1204-6. [Abstract] [Full-text]
42. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
    Pediatr Blood Cancer, 55(6): 1096-102. [Abstract] [Full-text]
43. Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.
    Pediatr Blood Cancer, 55(6): 1224-6. [Abstract] [Full-text]
44. Anaplastic ependymoma with sclerotic bone metastases.
    Pediatr Blood Cancer, 55(6): 1204-6. [Abstract] [Full-text]
45. Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
    Pediatr Blood Cancer, 55(6): 1096-102. [Abstract] [Full-text]
46. KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells.
    Pediatr Blood Cancer, 55(7): 1300-5. [Abstract] [Full-text]
47. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
    Pediatr Blood Cancer, 55(7): 1296-9. [Abstract] [Full-text]
48. Sexual function in adolescent and young adult survivors of lower extremity bone tumors.
    Pediatr Blood Cancer, 55(7): 1370-6. [Abstract] [Full-text]
49. KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells.
    Pediatr Blood Cancer, 55(7): 1300-5. [Abstract] [Full-text]
50. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
    Pediatr Blood Cancer, 55(7): 1296-9. [Abstract] [Full-text]
51. Sexual function in adolescent and young adult survivors of lower extremity bone tumors.
    Pediatr Blood Cancer, 55(7): 1370-6. [Abstract] [Full-text]
52. KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells.
    Pediatr Blood Cancer, 55(7): 1300-5. [Abstract] [Full-text]
53. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
    Pediatr Blood Cancer, 55(7): 1296-9. [Abstract] [Full-text]
54. Sexual function in adolescent and young adult survivors of lower extremity bone tumors.
    Pediatr Blood Cancer, 55(7): 1370-6. [Abstract] [Full-text]

© 2004-2011 Bone Cancer Research Today. All Rights Reserved.